Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies. (Stocks include CYCC, VVUS, CLDX)
The Next Big Thing in Biotech: Discovery Labs
Senior columnist Adam Feuerstein explains why Discovery Labs is the next big thing in biotech.
The 5 Dumbest Things on Wall Street -- Silent Movie Version
The show must go on, even if the host loses his voice.
New fees from Bank of America revives debate on whether banks can offset revenue losses by charging customers. 9 Gold, Oil Stocks That Rise on Bad News (Update 1)
These companies thrive on political and economic uncertainty -- two things that are certain for the rest of the year. Investors May Cry For Yelp After IPO (Update 1)
Reviews site Yelp is going public today. Investors may want to stay away for a variety of reasons. 7 Ex-Dividend Stocks With Buy Ratings
These stocks, which go ex-dividend Monday, are rated buy at TheStreet Ratings. Stocks Waver as Investors Eye Europe
Stocks waver as European markets weaken and investors watch for developments in Greece's bailout. Bank Rate Bomb Will Destroy the Smallest and Weakest
Philip van Doorn
The nation's community banks had better be prepared for the possibility of a quick spike in rates of up to 400 basis points within the next few years. 7 Dividend Stocks That Want to Pay You More Cash
These companies recently increased their dividend payouts to shareholders.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV